Literature DB >> 685997

Recurrent hepatitis following halothane exposures.

W Schlippert, S Anuras.   

Abstract

The existence of hepatotoxicity due to halothane remains subject to debate. Three cases are presented in which multiple exposures to halothane were followed in several instances by evidence of postoperative fever and/or hepatitis. In one case, hepatitis with bridging necrosis developed; the patient responded to long-term steroid therapy. In another, fulminant hepatic necrosis proved fatal. A brief review of halothane hepatitis is given. Otherwise unexplained fever and hepatitis following the use of halothane, especially if recurrent or accompanied by evidence of hypersensitivity, should contraindicate subsequent use of that drug.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 685997     DOI: 10.1016/0002-9343(78)90688-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Halothane and liver damage.

Authors:  D Rosenak; A Halevy; R Orda
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

2.  Medical evaluation before operation.

Authors:  D L Elliot; D H Linz; J A Kane
Journal:  West J Med       Date:  1982-10

3.  Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.

Authors:  J Ludwig
Journal:  Dig Dis Sci       Date:  1979-10       Impact factor: 3.199

4.  Prolonged halothane hepatitis. Prompt resolution of severe lesion with corticosteroid therapy.

Authors:  D H Moore; G D Benson
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

5.  [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].

Authors:  H Voigt; J Caselitz; M Jänner
Journal:  Klin Wochenschr       Date:  1981-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.